Proliferative classification of intracranially injected HER2-positive breast cancer cell lines

Yuka Kuroiwa, Jun Nakayama, Chihiro Adachi, Takafumi Inoue, Shinya Watanabe, Kentaro Semba

研究成果: Article査読

1 被引用数 (Scopus)

抄録

HER2 is overexpressed in 25–30% of breast cancers, and approximately 30% of HER2-positive breast cancers metastasize to the brain. Although the incidence of brain metastasis in HER2-positive breast cancer is high, previous studies have been mainly based on cell lines of the triple-negative subtype, and the molecular mechanisms of brain metastasis in HER2-positive breast cancer are unclear. In the present study, we performed intracranial injection using nine HER2-positive breast cancer cell lines to evaluate their proliferative activity in brain tissue. Our results show that UACC-893 and MDA-MB-453 cells rapidly proliferated in the brain parenchyma, while the other seven cell lines moderately or slowly proliferated. Among these nine cell lines, the proliferative activity in brain tissue was not correlated with either the HER2 level or the HER2 phosphorylation status. To extract signature genes associated with brain colonization, we conducted microarray analysis and found that these two cell lines shared 138 gene expression patterns. Moreover, some of these genes were correlated with poor prognosis in HER2-positive breast cancer patients. Our findings might be helpful for further studying brain metastasis in HER2-positive breast cancer.

本文言語English
論文番号1811
ページ(範囲)1-18
ページ数18
ジャーナルCancers
12
7
DOI
出版ステータスPublished - 2020 7

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

フィンガープリント 「Proliferative classification of intracranially injected HER2-positive breast cancer cell lines」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル